Pro: Inhaled prostaglandin as a pulmonary vasodilator instead of nitric oxide

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 19, Issue 3, 2005, Pages 400-402

  Augoustides, John G ^a   Ochroch, E Andrew ^a   Dickstein, Marc L ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Nitric oxide; Prostaglandin; Vasodilation

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; HEMOGLOBIN; ILOPROST; MILRINONE; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT;

CLINICAL TRIAL; DRUG BINDING; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; ENZYME ACTIVATION; FLOW RATE; HEART SURGERY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYDROLYSIS KINETICS; LUNG BLOOD FLOW; LUNG EDEMA; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

EID: 20444364222     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.03.036     Document Type: Note

References (40)

1. A. Maslow M. Regan P. Panzica Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction Anesth Analg 95 2002 1507 1518
2. K. Fukamachi P.M. McCarthy N. Smedira Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Ann Thor Surg 68 1999 2181 2184
3. J.G. Augoustides E.A. Ochroch Perioperative use of nitric oxide in cardiothoracic anesthesia and intensive care Prog Anesth 15 2001 115 124
4. J.G. Augoustides D.J. Mancini Postoperative care of the adult cardiac surgical patient Prog Anesth 16 2002 99 112
5. W. Steudel W. Hurford W. Zapol Inhaled nitric oxide Basic biology and clinical applications Anesthesiology 91 1999 1090 1121
6. G. Blaise D. Langleben B. Hubert Pulmonary arterial hypertension Pathophysiology and anesthetic approach Anesthesiology 99 2003 1415 1432
7. L.G. Fischer H. Van Atken H. Burkle Management of pulmonary hypertension and pharmacological considerations for anesthesiologists Anesth Analg 96 2003 1603 1616
8. M.J. Semigran B.A. Cockrill R. Kacmarek Hemodynamic effects of inhaled nitric oxide in heart failure J Am Coll Cardiol 24 1994 982 988
9. E. Loh J.S. Stamler J.M. Hare Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction Circulation 90 1994 2780 2785
10. O. Miller S. Tang A. Keech Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide Lancet 346 1995 51 52
11. C.K. Samama M. Diaby J.L. Fellahi Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome Anesthesiology 83 1995 56 65
12. S.M. Lowson H.M. Hassan G.F. Rich The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit Anesth Analg 89 1999 1360 1365
13. S.M. Lowson Inhaled alternatives to nitric oxide Anesthesiology 96 2002 1504 1513
14. J.R. Vane R.M. Botting Pharmacodynamic profile of prostacyclin Am J Cardiol 75 1995 3A 10A
15. S.M. Lowson A. Doctor B.K. Walsh Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery Crit Care Med 30 2002 2762 2764
16. B. Zwissler M. Welte K. Messmer Effects of inhaled prostacyclin as compared to inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction J Cardiothorac Vasc Anesth 9 1995 283 289
17. M. Max R. Kublen R. Dembinski Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension Intensive Care Med 25 1999 1147 1154
18. M. Booke D. Bradford F. Hinder Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep Crit Care Med 24 1996 1841 1848
19. L. Hill R. Pearl Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension J Appl Physiol 86 1999 1160 1164
20. G. Mikhail S. Gibbs G. Richardson An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension Eur Heart J 18 1997 1499 1504
21. G. Cremona T. Higenbottam Role of prostacyclin in the treatment of primary pulmonary hypertension Am J Cardiol 75 1995 67A 71A
22. S. Webb S. Stott P. van Heerden The use of inhaled aerosolized prostacyclin in the treatment of pulmonary hypertension secondary to pulmonary embolism Intensive Care Med 22 1996 353 355
23. A. Haraldsson N. Kieler-Jensen S. Ricksten Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation J Cardiothorac Vasc Anesth 10 1996 864 868
24. 2 for acute pulmonary hypertension and right ventricular failure Anesth Analg 91 2000 291 295
25. G. Della Rocca C. Coccia M. Costa Inhaled aerosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation Transplant Proc 33 2001 1634 1636
26. A. Haraldsson N. Kieler-Jensen U. Nathorst-Westfelt Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance Chest 114 1998 780 786
27. O. Eichelbronner H. Reinelt H. Wiedeck Aerosolized prostacyclin and inhaled nitric oxide in septic shock Different effects on splanchnic oxygenation Intensive Care Med 22 1996 880 887
28. J.G.T. Augoustides K. Culp S. Smith Rebound pulmonary hypertension and cardiogenic shock after withdrawal of inhaled prostacyclin Anesthesiology 100 2004 1023 1025
29. H. Olschewski D. Walmrath R. Schermuly Aerosolized prostacyclin and iloprost in severe pulmonary hypertension Ann Int Med 124 1996 820 824
30. M. Hoeper H. Olschewski H. Ghofrani A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension J Am Coll Cardiol 35 2000 176 182
31. S. Grant K. Goa Iloprost A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischemia, and extracorporeal circulation procedures Drugs 43 1999 889 924
32. S. Rex T. Busch M. Vettelschoss Intraoperative management of severe pulmonary hypertension during cardiac surgery with inhaled iloprost Anesthesiology 99 2003 745 747
33. M. Muller S. Scholz M. Kwapisz Use of inhaled iloprost in a case of pulmonary hypertension during pediatric congenital heart surgery Anesthesiology 99 2003 743 744
34. G.S. Raja Treatment of rebound pulmonary hypertension Why not sildenafil? Anesthesiology 101 2004 1480 (letter)
35. J.G.T. Augoustides Treatment of rebound pulmonary hypertension Why not sildenafil? (in reply) Anesthesiology 101 2004 1480 (letter)
36. A.M. Atz A.K. Lefler D.L. Fairbrother Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises J Thorac Cardiovasc Surg 124 2002 628 629
37. E. Michelakis W. Tymchak D. Lien Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension Comparison with inhaled nitric oxide Circulation 105 2002 2398 2403
38. A.M. Atz D.L. Wessel Sildenafil ameliorates effects of inhaled nitric oxide withdrawal Anesthesiology 91 1999 307 310
39. D. Walmrath T. Schneider R. Schermuly Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome Am J Respir Crit Care Med 153 1996 991 996
40. B. Zwissler G. Kemming O. Habler Inhaled prostacyclin versus inhaled nitric oxide in adult respiratory distress syndrome Am J Respir Crit Care Med 154 1996 1671 1677